装有纳法莫斯塔特的ACE2-诱-合PLGA-PEG纳米颗粒具有强大的抗病毒活性
Shulin Hou1, Yunyun Zhang1,2, Xin Zheng1,2
1Shanxi Key Laboratory of Birth Defect and Cell Regeneration, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Department of Biochemistry and Molecular Biology, College of Basic Medicine, Shanxi Medical University, Taiyuan 030001, China.
Viruses
|September 27, 2025
概括
研究人员开发了封装纳法莫斯塔特 (NM) 的新型纳米粒子,并准了ACE2受体. 这些纳米药物对SARS-CoV-2及其变体具有强大的抗病毒活性,提供了一个有前途的COVID-19治疗策略.
科学领域:
- 纳米医学是一种纳米医学.
- 病毒学 病毒学
- 药物运输 药物运输 药物运输
背景情况:
- ангиотензин转化酶2 (ACE2) 对于SARS-CoV-2进入宿主细胞至关重要.
- 纳法莫斯塔特 (NM) 具有抗病毒和抗炎性质,有利于COVID-19治疗.
研究的目的:
- 开发和描述用于针对SARS-CoV-2的纳法莫斯塔特 (NM) 封装的新型纳米粒子.
- 评估这些纳米药物对SARS-CoV-2及其变体的抗病毒疗效.
主要方法:
- 聚合物纳米粒子 (PLGA-PEG) 被制成以封装纳法莫斯塔特 (NM).
- 纳米粒子与ACE2诱 (CTC-445.2d或SI5α) 结合在一起.
- 物理化学性质,稳定性,药物释放和抗病毒活性在体外进行了评估.
主要成果:
- 开发的纳米粒子 (NM-PP-Pro/Pep NPs) 显示出统一的尺寸 (<200 nm) 和稳定性.
- 从纳米粒子中观察到NM的持续和受控释放.
- NM-PP-Pro NPs在体外对野生型SARS-CoV-2 (IC50 <0.05 nM) 和D614G变种 (IC50 = 2 nM) 显示出强大的抗病毒活性.
结论:
- 装有NAFMOSTAT的纳米颗粒是一种有前途的纳米治疗平台.
- 这种方法显示了有效准SARS-CoV-2及其演变变异的潜力.
相关概念视频
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...